The importance of the pathologist's role in assessment of the quality of the mesorectum

Current Colorectal Cancer Reports

Volumn 8, Issue 2, 2012, Pages 90-98

  Bosch, Steven L ^a   Nagtegaal, Iris D ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Mesorectum; Pathology; Plane of surgery; Quality of surgery; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; MESORECTAL FAT ENVELOPE; MESORECTUM; MUSCULARIS PROPRIA; OVERALL SURVIVAL; PATHOLOGIST; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM SURGERY; ROBOTICS; SURGICAL ANATOMY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TOTAL MESORECTAL EXCISION; TREATMENT OUTCOME;

EID: 84869112922     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-012-0124-7     Document Type: Article

References (38)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-The clue to pelvic recurrence? Br J Surg. 1982;69:613-6.
2. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479-82.
3. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341(8843):457-60.
4. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693-701.
5. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356(9224):93-6.
6. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet. 2009;373(9666):811-20.
7. Parfitt JR, Driman DK. The total mesorectal excision specimen for rectal cancer: A review of its pathological assessment. J Clin Pathol. 2007;60(8):849-55.
8. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303-12.
9. Nagtegaal ID, van de Velde CJ, van derWorp E, et al. Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20 (7):1729-34.
10. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373 (9666):821-8.
11. Nagtegaal ID, van Krieken JH. The multidisciplinary treatment of rectal cancer: Pathology. Ann Oncol. 2007;18 Suppl 9:ix122-6.
12. Bretagnol F, Lelong B, Laurent C, et al. The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma. Surg Endosc. 2005;19(7):892-6.
13. Baik SH, Kim NK, Lee KY, et al. Factors influencing pathologic results after total mesorectal excision for rectal cancer: Analysis of consecutive 100 cases. Ann Surg Oncol. 2008;15(3):721-8.
14. Nagtegaal ID, van de Velde CJH, Marijnen CA, et al. Low rectal cancer: A call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23(36):9257-64.
15. Baik SH, Kwon HY, Kim JS, et al. Robotic versus laparoscopic low anterior resection of rectal cancer: Short-term outcome of a prospective comparative study. Ann Surg Oncol. 2009;16 (6):1480-7.
16. Jeyarajah S, Sutton CD, Miller AS, Hemingway D. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis. 2007;9(9):808-15.
17. Maslekar S, Sharma A, Macdonald A, et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007;50(2):168-75.
18. Leite JS, Martins SC, Oliveira J, et al. Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer. Colorectal Dis. 2011;13(4):381-6.
19. Garcia-Granero E, Faiz O, Munoz E, et al. Macroscopic assessment of mesorectal excision in rectal cancer: A useful tool for improving quality control in a multidisciplinary team. Cancer. 2009;115(15):3400-11.
20. Leonard D, Penninckx F, Fieuws S, et al. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252(6):982-8.
21. Breukink SO, Grond AJ, Pierie JP, et al. Laparoscopic vs open total mesorectal excision for rectal cancer: An evaluation of the mesorectum's macroscopic quality. Surg Endosc. 2005;19(3):307-10.
22. Biondo S, Ortiz H, Lujan J, et al. Quality of mesorectum after laparoscopic resection for rectal cancer - results of an audited teaching programme in Spain. Colorectal Dis. 2010;12(1):24- 31.
23. Gouvas N, Tsiaoussis J, Pechlivanides G, et al. Quality of surgery for rectal carcinoma: Comparison between open and laparoscopic approaches. Am J Surg. 2009;198(5):702-8.
24. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): Short-term outcomes of an openlabel randomised controlled trial. Lancet Oncol. 2010;11(7):637- 45.
25. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449-57.
26. Tekkis PP, Heriot AG, Smith J, et al. Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis. 2005;7(4):369-74.
27. Lujan J, Valero G, Hernandez Q, et al. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg. 2009;96(9):982-9.
28. Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97(11):1638-45.
29. Ng SS, Leung KL, Lee JF, et al. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: A prospective randomized trial. Ann Surg Oncol. 2008;15(9):2418-25.
30. Rullier E, Sa CA, Couderc P, et al. Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg. 2003;90(4):445-51.
31. Baek JH, McKenzie S, Garcia-Aguilar J, Pigazzi A. Oncologic outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer. Ann Surg. 2010;251(5):882-6. This is the only study comparing.
32. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: The next challenge after total mesorectal excision. Ann Surg. 2005;242(1):74-82.
33. Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: Anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47(1):48-58.
34. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731-40.
35. Martling A, Holm T, Johansson H, et al. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: Long-term follow-up of a population-based study. Cancer. 2001;92(4):896-902.
36. Boyle KM, Petty D, Chalmers AG, et al. MRI assessment of the bony pelvis may help predict resectability of rectal cancer. Colorectal Dis. 2005;7(3):232-40.
37. Chambers W, Collins G, Warren B, et al. Benchmarking circumferential resection margin (R1) resection rate for rectal cancer in the neoadjuvant era. Colorectal Dis. 2010;12(9):909-13.
38. Youssef H, Collantes EC, Rashid SH, et al. Rectal cancer: Involved circumferential resection margin - A root cause analysis. Colorectal Dis. 2009;11(5):470-4.